Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Trading Statement

3 Feb 2014 07:00

3 February 2014

Anpario plc

(“the Company” or “Anpario”)

Pre Close Trading Statement

Anpario, the international producer of natural feed additives for animal health, hygiene and nutrition, is pleased to release a Pre Close Trading Statement.

The Company expects to deliver results for the year ended 31December 2013 in line with market expectations. The results will be announced in early April 2014.

Anpario has delivered strong sales growth from all its international brands and this advance reflects the Company’s investment in expanding its sales and technical resources at its regional offices in Brazil, China and Malaysia.

The growing interest from potential customers in North America has encouraged the Company to establish a subsidiary in the United States. This new, wholly owned, subsidiary is based in South Carolina and includes sales, warehousing and distribution facilities to enable it to offer Anpario’s products throughout North America.

The United States operation complements subsidiaries already formed in Brazil and China and means the Company is now firmly located in the world’s three principal pig and poultry producing countries. These businesses serve territories which in total account for over half the world’s output of pigs and poultry and will provide a strong platform for future growth.

The balance sheet remains strong and debt free with cash balances of £4.8m at the year end.

The Company is greatly encouraged by the number of new opportunities opening up in existing and new markets as customers become increasingly aware of the performance enhancing value of Anpario’s product portfolio. Customers recognise the benefit of Anpario’s natural products that are increasingly replacing the traditional use of antibiotics. The Company’s investment in developing its product ranges backed by experienced sales teams has placed it in a strong position to maintain its growth record.

Anpario plc
David Bullen, Chief Executive Officer +44 (0)791 955 2040
Karen Prior, Group Finance Director +44 (0)1909 537 380
FinnCap
Matthew Robinson / Henrik Persson - Corporate Finance
Stephen Norcross - Corporate Broking +44 (0)20 7600 1658

Copyright Business Wire 2014

Date   Source Headline
23rd Oct 20087:00 amRNSAnglo Platinum Quarterly Review and Prod Report
23rd Sep 200812:00 pmRNSDirectorate Change
20th Aug 20089:42 amRNSDividend Declaration
1st Aug 20084:30 pmRNSDirector/PDMR Shareholding
28th Jul 20088:00 amRNSInterim Results
28th Jul 20088:00 amRNSAnglo Platinum Limited
23rd Jul 200812:32 pmRNSBlocklisting Interim Review
18th Jul 20082:32 pmRNSBlocklisting Interim Review
17th Jul 200812:15 pmRNSBlocklisting Interim Review
15th Jul 200811:19 amRNSBlocklisting Interim Review
14th Jul 200811:36 amRNSTrading Statement
2nd Jul 20083:07 pmRNSDirectorate Change
13th May 20089:34 amRNSDirectorate Change
13th May 20089:30 amRNSAnglo Platinum CEO
30th Apr 20082:31 pmRNSDividend Declaration
29th Apr 200811:25 amRNSNew order mining rights
29th Apr 200811:03 amRNSMining Rights Conversions
29th Apr 20087:00 amRNSFirst Quarter Review
2nd Apr 20087:00 amRNSFinal Results
11th Mar 20089:43 amRNSDividend conversion rate
10th Mar 20081:04 pmRNSRevised Conversion Price
7th Mar 20081:54 pmRNSDirector/PDMR Shareholding
7th Mar 20089:35 amRNSEmployee Share Scheme
15th Feb 20089:18 amRNSSmelter Shutdown
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSAnglo Platinum
31st Jan 20089:50 amRNSPlatinum Transaction
31st Jan 20089:27 amRNSJoint Transaction
25th Jan 20085:38 pmRNSEnergy Supply Talks
23rd Jan 20082:24 pmRNSInterruption: Mine Production
23rd Jan 200811:07 amRNSDirectorate Change
17th Jan 20089:57 amRNSBlocklisting Interim Review
11th Jan 200812:16 pmRNSBlock listing application
16th Nov 20072:00 pmRNSAnglo Platinum Announcement
16th Nov 20071:56 pmRNSReduction in target
7th Nov 200710:12 amRNSProposed Transactions
2nd Nov 20072:00 pmRNSDirectorate Change
26th Oct 20073:02 pmRNSDividend Declaration
11th Oct 20071:00 pmRNSDirectorate Change
1st Oct 20073:03 pmRNSDirector/PDMR Shareholding
25th Sep 20077:01 amRNSInterim Results
4th Sep 20077:01 amRNSNotification
24th Aug 20073:23 pmRNSWage negotiations
22nd Aug 20079:09 amRNSDividend Conversion Rate
6th Aug 20074:13 pmRNSDirector/PDMR Shareholding
1st Aug 20077:02 amRNSChange of Adviser
30th Jul 200712:43 pmRNSDirectorate Change
30th Jul 20078:00 amRNSInterim Results
30th Jul 20078:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.